Effectiveness and limitation of gamma knife radiosurgery for relapsed central nervous system lymphoma: A retrospective analysis in one institution

International Journal of Hematology

Volumn 85, Issue 4, 2007, Pages 333-337

  Matsumoto, Yosuke ^a   Horiike, Shigeo ^a   Fujimoto, Yoshiko ^a   Shimizu, Daisuke ^a   Kudo Nakata, Yuriko ^a   Kimura, Satoshi ^a   Sato, Manabu ^b   Nomura, Kenichi ^a   Kaneko, Hiroto ^c   Kobayashi, Yutaka ^a   Shimazaki, Chihiro ^a   Taniwaki, Masafumi ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Rakusai Shimizu Hospital   (Japan)

^c Aiseikai Yamashina Hospital   (Japan)

Author keywords

CNS lymphoma; Diffuse large B cell lymphoma; Gamma Knife radiosurgery; Retrospective analysis

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CONTROL; CANCER RELAPSE; CANCER SURVIVAL; CASE REPORT; CENTRAL NERVOUS SYSTEM LYMPHOMA; CENTRAL NERVOUS SYSTEM TUMOR; DRUG MEGADOSE; FEMALE; GAMMA KNIFE RADIOSURGERY; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; RETROSPECTIVE STUDY; SURVIVAL TIME; SYMPTOMATOLOGY; SYSTEMIC DISEASE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; RADIOSURGERY; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 34547546136     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.06205     Document Type: Article

References (25)

1. Krogh-Jensen M, d'Amore F, Jensen MK, et al. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas: population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO. Ann Oncol. 1994;5:349-354.
2. DeAngelis LM. Primary central nervous system lymphoma: a new clinical challenge. Neurology. 1991;41:619-621.
3. Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J Clin Oncol. 2000;18:3144-3150.
4. DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol. 2002;20:4643-4648.
5. Bollen EL, Brouwer RE, Hamers S, et al. Central nervous system relapse in non-Hodgkin lymphoma: a single-center study of 532 patients. Arch Neurol. 1997;54:854-859.
6. Hoerni-Simon G, Suchaud JP, Eghbali H, et al. Secondary involvement of the central nervous system in malignant non-Hodgkin's lymphoma: a study of 30 cases in a series of 498 patients. Oncology. 1987;44:98-101.
7. Bashir RM, Bierman PJ, Vose JM, et al. Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma. Am J Clin Oncol. 1991;14:478-482.
8. Recht L, Straus DJ, Cirrincione C, et al. Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis. Am J Med. 1988;84:425-435.
9. van Besien K, Ha CS, Murphy S, et al. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood. 1998;91:1178-1184.
10. Zinzani PL, Magagnoli M, Frezza G, et al. Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience. Leuk Lymphoma. 1999;32:571-576.
11. Hollender A, Kvaloy S, Lote K, Nome O, Holte H. Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement: a single centre analysis. Eur J Cancer. 2000;36:1762-1768.
12. Bokstein F, Lossos A, Lossos IS, Siegal T. Central nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy. Leuk Lymphoma. 2002;43:587-593.
13. Jahnke K, Thiel E, Martus P, Schwartz S, Korfel A. Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system. Ann Haematol. 2005;85: 45-50.
14. Jahnke K, Thiel E, Martus P, et al, on behalf of the German Primary Central Nervous System Lymphoma Study Group (G-PCNSL-SG). Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J Neurooncol. 2006;80:159-165.
15. Kawamura T, Koga S, Okamoto M, Kanno T, Iwamura H. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS). Rad Med. 2001;19:145-149.
16. Nicolato A, Gerosa MA, Foroni R, et al. Gamma Knife radiosurgery in AIDS-related primary central nervous system lymphoma. Stereotact Funct Neurosurg. 1995;64(suppl 1):42-55.
17. Dong Y, Pan L, Wang B, et al. Stereotactic radiosurgery in the treatment of primary central nervous system lymphoma. Chin Med J (Engl). 2003;116:1166-1170.
18. Campbell PG, Jawahar A, Fowler MR, Delaune A, Nanda A. Primary central nervous system lymphoma of the brain stem responding favorably to radiosurgery: a case report and literature review. Surg Neurol. 2005;64:400-405.
19. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665-1672.
20. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas: NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244-1253.
21. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989;7: 1630-1636.
22. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989;39:789-796.
23. Vigliani MC, Duyckaerts C, Hauw JJ, Poisson M, Magdelenat H, Delattre JY. Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: a clinical and pathological study. J Neurooncol. 1999;41:137-149.
24. Lai R, Abrey LE, Rosenblum MK, DeAngelis LM. Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study. Neurology. 2004;62:451-456.
25. Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T, Fukushima T. Long-term remission of primary central nervous system lymphoma by intensified methotrexate chemotherapy. J Neurooncol. 2003;63:87-95.